￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
028-123456789
Menu

Medical News

A TKI with dual inhibitory activity of ALK and ROS1: ceritinib

2025-10-19 11:44:20

Check Details
Medication methods and side effects of the lung cancer targeted drug alectinib

2025-10-19 11:44:20

Check Details
Which generation of targeted drug is crizotinib? How should it be used?

2025-10-19 11:44:20

Check Details
What is the dosage of rupitidine? Is rubitidine effective in treating lung cancer

2025-10-19 11:44:20

Check Details
Osimertinib changes cancer outcomes and bids farewell to chemotherapy side effects

2025-10-19 11:44:20

Check Details
Serpatinib Retevmo brings new treatment option to lung cancer patients

2025-10-19 11:44:20

Check Details
Erlotinib or gefitinib, which one should I choose?

2025-10-19 11:44:20

Check Details
Gefitinib combined with lenvatinib is a potential therapy for advanced HCC_ Kanghule

2025-10-19 11:44:20

Check Details
Entrectinib can significantly improve the response rate of lung cancer patients

2025-10-19 11:44:20

Check Details
Mobotinib is an oral therapy for the treatment of lung cancer with EGFR exon 20 insertion mutation

2025-10-19 11:44:20

Check Details
How effective is Rybrevant in treating non-small cell lung cancer? How long does it take to see the effect

2025-10-19 11:44:20

Check Details
How effective is Tepotinib? What are the precautions for using Tepotinib?

2025-10-19 11:44:20

Check Details
Category
相关知识